Having been the company’s tax advisor for over 20 years, we started to reflect with the global tax and finance team on their tax transformation journey early 2019. As various ideas were being considered, we launched a tax transformation lab in 2020 where the power of Deloitte as a global firm showed strength, innovation and agility. Teams from the Netherlands, the UK, Singapore and the US were determined to make our impact count.
In December 2020, the global company issued an official request for information (RFI) for the three-year contract. We positioned ourselves as a trusted partner, focusing on three key pillars: transformational compliance, harnessing the power of technology, and elevating the tax function.
By combining forces across member firms and disciplines, and positioning Deloitte as the innovator amongst the five firms in the running, but above all a partner that will walk alongside the biopharmaceutical company’s tax team, we secured the incredible strategic win.